GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (STU:AWY0) » Definitions » YoY EPS Growth

Percheron Therapeutics (STU:AWY0) YoY EPS Growth : -50.00% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Percheron Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Percheron Therapeutics's YoY EPS Growth for the quarter that ended in Dec. 2024 was -50.00%.

Percheron Therapeutics's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was €-0.01.

Percheron Therapeutics YoY EPS Growth Historical Data

The historical data trend for Percheron Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Percheron Therapeutics YoY EPS Growth Chart

Percheron Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -60.00 -12.50 33.33 -83.33 27.27

Percheron Therapeutics Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -66.67 -100.00 20.00 33.33 -50.00

Percheron Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Percheron Therapeutics's YoY EPS Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EPS Growth (A: Jun. 2024 )
=(Earnings per Share (Diluted) (A: Jun. 2024 )-Earnings per Share (Diluted) (A: Jun. 2023 ))/ | Earnings per Share (Diluted) (A: Jun. 2023 ) |
=(-0.008--0.011)/ | -0.011 |
=27.27 %

Percheron Therapeutics's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(-0.006--0.004)/ | -0.004 |
=-50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Percheron Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Percheron Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (STU:AWY0) » Definitions » YoY EPS Growth
Comparable Companies
ASX:AGH ASX:CAN ASX:RGT ASX:EOF ASX:IVX ASX:ECS ASX:EXL ASX:BP8 ASX:NXS ASX:LGP ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
PERCF:USA AWY0:Germany PER:Australia
Address
14 Wallace Avenue, LEVEL 1, Toorak, VIC, AUS, 3142
Website
https://www.percherontx.com
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.

Percheron Therapeutics Headlines

No Headlines